6. Toward a new Solvay

2008 - Tomorrow

  Background_06_Towards_resized Click to enlarge
Recent years have witnessed an intense transformation of the Group’s profile. The divestment of the pharma business and the acquisition of Rhodia in only two years’ time radically modified the perimeter and the strategy of the Group, which keeps however building on its rich heritage.